Skip to content
Wenlo
Sign in
← Markets

ResMed Inc.

Christopher DelOrefice (Director) reports RMD insider transactions

4RMDFiled Nov 20, 2026, 6:22 PM ET· Period Nov 19, 2026

AI-generated summary

Director Christopher DelOrefice received 554 shares as a grant of ResMed Common Stock on November 19, 2026. Following this transaction, the insider directly holds 2,977 shares. The shares were awarded as Restricted Stock Units.

Key facts

Insider
Christopher DelOrefice · Director
DateTransactionSharesPriceValueHeld afterOwnership
Nov 19, 2026A · grantFootnotes F1+554$0.00$0.002,977Direct
Footnotes
  1. F1 Shares awarded represent Restricted Stock Units. The RSUs vest in full on the earlier of 11/11/2027, or the annual meeting of stockholders in the year following the grant date.

More RMD filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.